Early detection of pulmonary ADC toxicity using ImmuONE’s morph_ONE™ high-content imaging assay of alveolar macrophages to improve safety and efficacy in ADC drug development.
Dr Abigail Martin and Professor Victoria Hutter have secured backing from the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia Ventures and part of the Midlands Engine Investment Fund (MEIF), Mercia’s EIS funds and Pioneer Group.
Scientists raise £2m for 3D human lung model to replace animal testing Read More »
Inhaled substances are primarily tested on rats for toxicity, but key differences between rat and human lungs suggest it’s time to look towards alternative methods.
Why in vitro methods are the future of risk assessments for inhaled substances Read More »
morph_ONE is a reproducible, mechanistic-driven assay that reveals how inhaled substances affect more than a dozen morphological and biochemical features of alveolar macrophages. The assay helps companies and researchers to correctly interpret the response of the immune system in the lungs to inhaled chemical products, improving product development and ensuring safety as well as saving time and money.
Reliable, reproducible, robust: morph_ONE for high content image analysis of the lung Read More »
Foetal bovine serum (FBS) is widely used in cell culture media, but may limit the human relevance of safety assessments. A new study demonstrates the successful transition of the TK6 cell line to an FBS-free medium.
Successful adaptation of TK6 cells to an animal-product-free culture medium Read More »
New research demonstrates how an analytical technique known as morphometric phenotyping can distinguish between the effects of different nicotine products on immune cells.
Immune cells show difference between e-cigarette and cigarette exposure Read More »
Make Every Breath Safe
Sycamore House
16 Leyden Road
Stevenage, Hertfordshire, UK
SG1 2BP
Copyright 2025 ImmuONE.
All rights reserved.